Capital Advisors Inc’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Capital Advisors Inc’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,523	Closed	-$239K	–	329
2024 Q1	$239K	Sell	2,523 -100	-4%	-$9.28K	0.01%	273
2023 Q4	$234K	Buy	+2,623	New	+$195K	0.01%	264
2023 Q3	–	Sell	-2,673	Closed	-$222K	–	284
2023 Q2	$222K	Hold	2,673	–	–	0.01%	250
2023 Q1	$204K	Buy	+2,673	New	+$222K	0.01%	244
2021 Q4	–	Sell	-140,846	Closed	-$17.7M	–	256
2021 Q3	$17.7M	Buy	140,846 +42,882	+44%	+$5.52M	0.53%	75
2021 Q2	$13.3M	Sell	97,964 -72,512	-43%	-$9.53M	0.4%	87
2021 Q1	$23.1M	Sell	170,476 -53,915	-24%	-$8.07M	0.76%	54
2020 Q4	$31.6M	Buy	224,391 +12,265	+6%	+$1.57M	1.13%	24
2020 Q3	$23.6M	Buy	212,126 +5,396	+3%	+$605K	0.96%	35
2020 Q2	$23.5M	Buy	206,730 +13,345	+7%	+$1.31M	0.98%	32
2020 Q1	$15M	Buy	193,385 +15,759	+9%	+$1.4M	0.81%	44
2019 Q4	$16.9M	Buy	177,626 +24,763	+16%	+$2.14M	0.73%	47
2019 Q3	$13.4M	Hold	152,863	–	–	0.66%	45
2019 Q2	$13.4M	Buy	152,863 +83,754	+121%	+$7.14M	0.66%	45
2019 Q1	$6.26M	Buy	69,109 +32,269	+88%	+$2.75M	0.67%	22
2018 Q4	$2.64M	Buy	+36,840	New	+$2.97M	0.17%	93

Other funds holding XBI

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Capital Advisors Inc's XBI Position: Q2 2024 in Review

Capital Advisors Inc sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 2,523 shares — an estimated $239K sold.

Capital Advisors Inc first reported a position in XBI in Q4 2018 and held it in 16 quarters. The position peaked at $31.6M in Q4 2020. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Capital Advisors Inc reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
Capital Advisors Inc sold 2,523 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $239K.
Capital Advisors Inc first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 16 quarters.
Capital Advisors Inc's State Street SPDR S&P Biotech ETF position peaked at $31.6M in Q4 2020.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Capital Advisors Inc's 13F filing for Q2 2024, filed 31 Jul 2024.